1. Adelaide Research & Scholarship

Browsing "University Library" by Author Sallustio, B.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 25 to 44 of 49 < previous   next >
PreviewIssue DateTitleAuthor(s)
2000Hepatic disposition of electrophilic acyl glucuronide conjugatesSallustio, B.; Sabordo, L.; Evans, A.; Nation, R.
2000Hepatic disposition of the acyl glucoronide 1-O-gemfibrozil--D-glucoronide: Effects of clofibric acid, acetaminophen, and acetaminophen glucuronideSabordo, L.; Sallustio, B.; Evans, A.; Nation, R.
1999Hepatic disposition of the acyl glucuronide1-0-gemfibrozil-β-D-glucuronide effects of dibromosulfophthalein in membrane transport and aglycone formationSabordo, L.; Sallustio, B.; Evans, A.; Nation, R.
2000In vitro covalent binding of Nafenopin-CoA to human liver proteinsSallustio, B.; Nunthasomboon, S.; Drogemuller, C.; Knights, K.
2001In vivo perturbation of rat hepatocyte canalicular membrane function by diclofenacSallustio, B.; Holbrook, F.
2014Interaction of terbinafine (anti-fungal agent) with perhexiline: a case reportSheikh, A.R.; Westley, I.; Sallustio, B.; Horowitz, J.D.; Beltrame, J.F.
1998Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine serviceMorris, R.; Black, A.; Harris, A.; Batty, A.; Sallustio, B.
2010LC-MS/MS for immunosuppressant therapeutic drug monitoringSallustio, B.
2011Measurement of Cyclosporine A in rat tissues and human kidney transplant biopsies - A method suitable for small (<1 mg) samplesNoll, B.; Coller, J.; Somogyi, A.; Morris, R.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.
2004Optimisation of the comet genotoxicity assay in freshly isolated murine hepatocytes: detection of strong in vitro DNA damaging properties for styreneFontaine, F.; DeGraaf, Y.; Ghaoui, R.; Sallustio, B.; Edwards, J.; Burcham, P.
2013Perhexiline maleate in the treatment of fibrodysplasia ossificans progressiva: an open-labeled clinical trialKitoh, H.; Achiwa, M.; Kaneko, H.; Mishima, K.; Matsushita, M.; Kadono, I.; Horowitz, J.; Sallustio, B.; Ohno, K.; Ishiguro, N.
2002Pharmacokinetics of the antianginal agent perhexiline: relationship between metabolic ratio and steady-state doseSallustio, B.; Westley, I.; Morris, R.
1995Reactivity of gemfibrozil 1-0-b acyl glucuronide: Pharmacokinetics of covalently bound gemfibrozil-protein adducts in ratsSallustio, B.; Foster, D.
2003Relationship between CYP2D6 genotype and plasma OH-perhexiline/perhexiline concentration ratio in angina patients.Sallustio, B.; Davies, B.; Coller, J.; James, H.; Gillis, D.; Somogyi, A.
2014Relationship between plasma, atrial and ventricular perhexiline concentrations in humans: insights into factors affecting myocardial uptakeDrury, N.; Licari, G.; Chong, C.; Howell, N.; Frenneaux, M.; Horowitz, J.; Pagano, D.; Sallustio, B.
2006Role of MRP2 in the hepatic disposition of mycophenolic acid and its glucuronide metabolites: Effect of cyclosporineWestley, I.; Brogan, L.; Morris, R.; Evans, A.; Sallustio, B.
1998Short-term myocardial uptake of d- and l-Sotalol in humans: relation to hemodynamic and electrophysiologic effectsRitchie, R.; Sallustio, B.; Hii, J.; Horowitz, J.
1999Some international approaches to aminoglycoside monitoring in the extended dosing interval eraMorris, R.; Sallustio, B.; Vinks, A.; LeGatt, D.; Verjee, Z.; Desoky, E.
2008Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexilineDavies, B.; Herbert, M.; Coller, J.; Somogyi, A.; Milne, R.; Sallustio, B.
2015Stereoselective handling of perhexiline: implications regarding accumulation within the human myocardiumChong, C.; Drury, N.; Licari, G.; Frenneaux, M.; Horowitz, J.; Pagano, D.; Sallustio, B.
Showing results 25 to 44 of 49 < previous   next >